0001209191-19-006605.txt : 20190201 0001209191-19-006605.hdr.sgml : 20190201 20190201182944 ACCESSION NUMBER: 0001209191-19-006605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190130 FILED AS OF DATE: 20190201 DATE AS OF CHANGE: 20190201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Majeti Ravindra CENTRAL INDEX KEY: 0001743839 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38554 FILM NUMBER: 19561192 MAIL ADDRESS: STREET 1: C/O FORTY SEVEN, INC. STREET 2: 1490 O'BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Forty Seven, Inc. CENTRAL INDEX KEY: 0001667633 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474065674 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1490 O'BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 352-4150 MAIL ADDRESS: STREET 1: 1490 O'BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-30 0 0001667633 Forty Seven, Inc. FTSV 0001743839 Majeti Ravindra C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025 1 0 0 0 Common Stock 2019-01-30 4 S 0 16166 14.4552 D 1522182 D Common Stock 2019-01-31 4 S 0 3834 14.5727 D 1518348 D The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $14.25 to $14.68, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $14.40 to $14.76, inclusive. /s/ John T. McKenna, Attorney-in-Fact for Ravindra Majeti 2019-02-01